Can recombinant thrombomodulin play a preventive role for veno-occlusive disease after haematopoietic stem cell transplantation?

Suppr

超能文献

作者信息

Nomura S, Ozasa R, Nakanishi T, Fujita S, Miyaji M, Mori S, Yokoi T, Ito T, Ishii K

出版信息

Thromb Haemost. 2011 Jun;105(6):1118-20. doi: 10.1160/TH10-12-0802. Epub 2011 Apr 7.

DOI:10.1160/TH10-12-0802

PMID:21647533

Abstract

摘要

相似文献

Can recombinant thrombomodulin play a preventive role for veno-occlusive disease after haematopoietic stem cell transplantation?

Thromb Haemost. 2011 Jun;105(6):1118-20. doi: 10.1160/TH10-12-0802. Epub 2011 Apr 7.

Immunogenomics and proteomics in hematopoietic stem cell transplantation: predicting post-hematopoietic stem cell transplant complications.

Cancer Treat Res. 2009;144:95-129. doi: 10.1007/978-0-387-78580-6_5.

IL-6 and IL-8 levels in plasma during hematopoietic progenitor transplantation.造血祖细胞移植期间血浆中的白细胞介素-6和白细胞介素-8水平。

Haematologica. 1998 Dec;83(12):1082-7.

Counting the cost: markers of endothelial damage in hematopoietic stem cell transplantation.计算代价：造血干细胞移植中内皮损伤的标志物

Bone Marrow Transplant. 2004 Dec;34(12):1015-23. doi: 10.1038/sj.bmt.1704733.

Vascular endothelium and graft-versus-host disease.血管内皮与移植物抗宿主病

Best Pract Res Clin Haematol. 2008 Jun;21(2):129-38. doi: 10.1016/j.beha.2008.02.003.

Hepatic veno-occlusive disease after stem cell transplantation in Japan.日本干细胞移植后的肝静脉闭塞病

Bone Marrow Transplant. 1999 Jul;24(2):223-4. doi: 10.1038/sj.bmt.1701873.

Successful treatment of sinusoidal obstructive syndrome after hematopoietic stem cell transplantation with recombinant human soluble thrombomodulin.

Bone Marrow Transplant. 2010 Apr;45(4):783-5. doi: 10.1038/bmt.2009.217. Epub 2009 Aug 31.

Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.异基因反应性作为血液系统恶性肿瘤治疗的治疗原则。非清髓性预处理的异基因造血细胞移植的临床和免疫学方面的研究。

Dan Med Bull. 2007 May;54(2):112-39.

Severe metabolic abnormalities after allogeneic hematopoietic cell transplantation.异基因造血细胞移植后的严重代谢异常

Bone Marrow Transplant. 2005 Jan;35(1):63-9. doi: 10.1038/sj.bmt.1704708.

Clinical importance of HLA-DPB1 in haematopoietic cell transplantation.HLA-DPB1在造血细胞移植中的临床重要性。

Tissue Antigens. 2007 Apr;69 Suppl 1:36-41. doi: 10.1111/j.1399-0039.2006.759_4.x.

引用本文的文献

Association of High Mobility Group Box-Protein 1 and Platelet Microparticles in Patients After Hematopoietic Stem Cell Transplantation.高迁移率族蛋白 B1 和血小板微粒在造血干细胞移植患者中的相关性研究。

Clin Appl Thromb Hemost. 2023 Jan-Dec;29:10760296231193398. doi: 10.1177/10760296231193398.

Biomarkers of graft--host disease: Understanding and applications for the future.移植物抗宿主病的生物标志物：对未来的理解与应用

World J Transplant. 2021 Aug 18;11(8):335-343. doi: 10.5500/wjt.v11.i8.335.

A critical role of the Gas6-Mer axis in endothelial dysfunction contributing to TA-TMA associated with GVHD.Gas6-Mer 轴在导致与移植物抗宿主病相关的 TA-TMA 中的内皮功能障碍中起着关键作用。

Blood Adv. 2019 Jul 23;3(14):2128-2143. doi: 10.1182/bloodadvances.2019000222.

Sinusoidal obstructive syndrome prophylaxis with recombinant human soluble thrombomodulin is feasible in gemtuzumab ozogamicin-treated patients undergoing allogeneic hematopoietic cell transplantation.

Bone Marrow Transplant. 2017 Jul;52(7):1068-1070. doi: 10.1038/bmt.2017.65. Epub 2017 Apr 3.

Potentially life-threatening coagulopathy associated with simultaneous reduction in coagulation and fibrinolytic function in pediatric acute leukemia after hematopoietic stem-cell transplantation.造血干细胞移植后小儿急性白血病中与凝血及纤溶功能同时降低相关的潜在危及生命的凝血病。

Int J Hematol. 2017 Jul;106(1):126-134. doi: 10.1007/s12185-017-2213-5. Epub 2017 Mar 16.

A donor thrombomodulin gene variation predicts graft-versus-host disease development and mortality after bone marrow transplantation.供体血栓调节蛋白基因变异可预测骨髓移植后移植物抗宿主病的发生及死亡率。

Int J Hematol. 2015 Oct;102(4):460-70. doi: 10.1007/s12185-015-1852-7. Epub 2015 Aug 6.

Thrombomodulin alleviates murine GVHD in association with an increase in the proportion of regulatory T cells in the spleen.血栓调节蛋白通过增加脾脏中调节性T细胞的比例来减轻小鼠移植物抗宿主病。

Bone Marrow Transplant. 2015 Jan;50(1):113-20. doi: 10.1038/bmt.2014.208. Epub 2014 Sep 22.

Improvement of high serum levels of biomarkers of endothelial injury after allogeneic hematopoietic SCT with pre-existing severe hepatitis using recombinant human soluble thrombomodulin.使用重组人可溶性血栓调节蛋白改善异基因造血干细胞移植后伴有既往严重肝炎的内皮损伤生物标志物高血清水平。

Bone Marrow Transplant. 2014 Nov;49(11):1444-5. doi: 10.1038/bmt.2014.156. Epub 2014 Jul 28.

Successful Control of Disseminated Intravascular Coagulation by Recombinant Thrombomodulin during Arsenic Trioxide Treatment in Relapsed Patient with Acute Promyelocytic Leukemia.重组血栓调节蛋白成功控制复发急性早幼粒细胞白血病患者三氧化二砷治疗期间的弥散性血管内凝血

Case Rep Hematol. 2012;2012:908196. doi: 10.1155/2012/908196. Epub 2012 Sep 12.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验